Application 201922

Type: NDA
Sponsor: JOURNEY

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	XIMINO	MINOCYCLINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	EQ 45MG BASE	No	No
002	XIMINO	MINOCYCLINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	EQ 67.5MG BASE	No	No
003	XIMINO	MINOCYCLINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	EQ 90MG BASE	No	No
004	XIMINO	MINOCYCLINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	EQ 112.5MG BASE	No	No
005	XIMINO	MINOCYCLINE HYDROCHLORIDE	CAPSULE, EXTENDED RELEASE;ORAL	EQ 135MG BASE	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
N201922-001	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11
N201922-002	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11
N201922-003	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11
N201922-004	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11
N201922-005	XIMINO	MINOCYCLINE HYDROCHLORIDE	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11

Orange Book patents#

Current patent rows page 1 of 1 · 9 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N201922-001	7919483	2027-03-07	U-124		2013-04-17
N201922-001	7541347	2027-04-02	U-917		2013-04-17
N201922-001	7544373	2027-04-02		Drug product	2013-04-17
N201922-003	7919483	2027-03-07	U-124
N201922-003	7541347	2027-04-02	U-917
N201922-003	7544373	2027-04-02		Drug product
N201922-005	7919483	2027-03-07	U-124
N201922-005	7541347	2027-04-02	U-917
N201922-005	7544373	2027-04-02		Drug product

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 215 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-001	XIMINO	EQ 45MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-002	XIMINO	EQ 67.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-003	XIMINO	EQ 90MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-004	XIMINO	EQ 112.5MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N201922-005	XIMINO	EQ 135MG BASE	CAPSULE, EXTENDED RELEASE / ORAL	2012-07-11	`03ed91905a0d…`

Observed Orange Book patent history#

Patent history page 1 of 19 · 738 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N201922-001	7919483	2027-03-07	U-124		2013-04-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-001	7541347	2027-04-02	U-917		2013-04-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-001	7544373	2027-04-02		Drug product	2013-04-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-003	7919483	2027-03-07	U-124			`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-003	7541347	2027-04-02	U-917			`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-003	7544373	2027-04-02		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-005	7919483	2027-03-07	U-124			`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-005	7541347	2027-04-02	U-917			`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N201922-005	7544373	2027-04-02		Drug product		`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N201922-001	7919483	2027-03-07	U-124		2013-04-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-001	7541347	2027-04-02	U-917		2013-04-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-001	7544373	2027-04-02		Drug product	2013-04-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-003	7919483	2027-03-07	U-124			`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-003	7541347	2027-04-02	U-917			`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-003	7544373	2027-04-02		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-005	7919483	2027-03-07	U-124			`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-005	7541347	2027-04-02	U-917			`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N201922-005	7544373	2027-04-02		Drug product		`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N201922-001	7919483	2027-03-07	U-124		2013-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-001	7541347	2027-04-02	U-917		2013-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-001	7544373	2027-04-02		Drug product	2013-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-003	7919483	2027-03-07	U-124			`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-003	7541347	2027-04-02	U-917			`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-003	7544373	2027-04-02		Drug product		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-005	7919483	2027-03-07	U-124			`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-005	7541347	2027-04-02	U-917			`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N201922-005	7544373	2027-04-02		Drug product		`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	7790705	2025-06-24	U-124		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	8252776	2025-06-24	U-124		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	8268804	2025-06-24	U-124		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	7919483	2027-03-07	U-124		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	7541347	2027-04-02	U-917		2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-001	7544373	2027-04-02		Drug product	2013-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	7790705	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	8252776	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	8268804	2025-06-24	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	7919483	2027-03-07	U-124			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	7541347	2027-04-02	U-917			`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-003	7544373	2027-04-02		Drug product		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N201922-005	7790705	2025-06-24	U-124			`31067a03dcf5…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 2 of 4 · 71 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	99825095-d897-4077-86df-483d505615b2	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	493bdeac-e073-4ec2-a481-85e6a6d3cb58	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	74946a91-b138-42cd-a9d4-58fe8f849270	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	653b22f3-9eb5-4c29-9b95-bc1c4f0273be	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	e1611d28-0c96-4ce2-ad5d-f62f66ec164d	2026-03-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	bb3b9a7e-6724-4c2a-b3cb-236f522b31a8	2026-03-09	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	A-S Medication Solutions	c96b1c5d-7004-4ee2-ad48-0ba963389f86	2026-02-19	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	REMEDYREPACK INC.	6597bdc9-9e3a-4c11-8b39-27b47f863287	2026-02-04	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline hydrochloride	MINOCYCLINE HYDROCHLORIDE	Northwind Health Company, LLC	0760232b-21a6-2b13-e063-6394a90a22c1	2026-01-01	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Northwind Health Company, LLC	12559b29-6568-4b99-a16e-6a87038981f7	2026-01-01	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline hydrochloride	MINOCYCLINE HYDROCHLORIDE	Northwind Health Company, LLC	f33fcfd2-b9ef-8e67-e053-2a95a90a0306	2026-01-01	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Ascend Laboratories, LLC	a8f95207-b259-4f50-87f2-3652d9268890	2025-12-18	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	6b2a7493-2e6c-4901-b697-17eb188cc8dd	2025-11-17	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocin	MINOCYCLINE HYDROCHLORIDE	Melinta Therapeutics, LLC	e415c323-8219-464b-9e3e-72c5a796cdaa	2025-09-11	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	e69284bc-0479-48d0-beb5-a26cfad6cd76	2025-08-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	2688e63a-09c7-4d73-a923-cf14fec7b1a4	2025-07-28	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	ddd22f2c-050b-4776-912b-39b3e6202c75	2025-07-28	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	American Health Packaging	94d941e3-d3d8-4414-bd5c-4a92848e738f	2025-07-25	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	9f4139e4-d4ab-46ea-a3f1-f719ab57a55e	2025-07-03	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE
Minocycline Hydrochloride	MINOCYCLINE HYDROCHLORIDE	Bryant Ranch Prepack	084fb405-fcb9-4db9-8d95-5a9c1d89f3b6	2025-07-03	Warnings, Adverse reactions	Name fallback generic name: MINOCYCLINE HYDROCHLORIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 12 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
10631-330	Ximino	minocycline hydrochloride	Sun Pharmaceutical Industries, Inc	NDA	Current
10631-331	Ximino	minocycline hydrochloride	Sun Pharmaceutical Industries, Inc	NDA	Current
10631-332	Ximino	minocycline hydrochloride	Sun Pharmaceutical Industries, Inc	NDA	Current
69489-121	Ximino	minocycline hydrochloride	Journey Medical Corporation	NDA	Current
69489-122	Ximino	minocycline hydrochloride	Journey Medical Corporation	NDA	Current
69489-123	Ximino	minocycline hydrochloride	Journey Medical Corporation	NDA	Current
72143-221	Minocycline Hydrochloride	minocycline hydrochloride	JG Pharma, Inc.	NDA	Current
72143-221	Minocycline Hydrochloride	minocycline hydrochloride	JG Pharma, Inc.	NDA	Current
72143-222	Minocycline Hydrochloride	minocycline hydrochloride	JG Pharma, Inc.	NDA	Current
72143-222	Minocycline Hydrochloride	minocycline hydrochloride	JG Pharma, Inc.	NDA	Current
72143-223	Minocycline Hydrochloride	minocycline hydrochloride	JG Pharma, Inc.	NDA	Current
72143-223	Minocycline Hydrochloride	minocycline hydrochloride	JG Pharma, Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
84945	SUPPL	2026-02-05
84881	SUPPL	2026-01-30
40092	SUPPL	2015-08-14
24404	ORIG	2013-08-13
22864	ORIG	2013-08-13
32147	ORIG	2012-07-13
19042	ORIG	2012-07-13